MRNA

Moderna
D

MRNA

51.375
USD
0.84
(1.65%)
مغلق
حجم التداول
411,709
الربح لكل سهم
-7
العائد الربحي
-
P/E
-6
حجم السوق
20,075,894,218
التوصيات
Strategic Pips
Strategic Pips
منذ 10 أشهر
buy
MRNA
MRNA @26.15
2025-04-14 07:32
MRNA@26.15 Chart
الربح
164.25
4.19%
Strategic Pips
Strategic Pips
منذ سنتين
sell
MRNA
MRNA @101.02
2024-02-01 04:45
MRNA@101.02 Chart
الربح
357.00
3.53%
Strategic Pips
Strategic Pips
منذ سنتين
sell
MRNA
MRNA @101.83
2024-01-29 05:09
MRNA@101.83 Chart
الربح
-175.00
-3.44%
المزيد
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ سنة
neutral
2024-10-01 05:30
MRNA Chart
المزيد
أصول ذات صلة الأخبار المقالات

العنوان: Moderna

القطاع: Healthcare
الصناعة: Biotechnology
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.